These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21977063)

  • 61. Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.
    Sullivan SD; Kahn SR; Davidson BL; Borris L; Bossuyt P; Raskob G
    Pharmacoeconomics; 2003; 21(7):477-96. PubMed ID: 12696988
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients.
    Du Plessis JA; Van Blydenstein SA; Wong M
    S Afr Med J; 2020 Feb; 110(3):235-242. PubMed ID: 32657702
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Results of ENDORSE-2-HUNGARIA study. Repeated assessment of the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].
    Losonczy H; Tar A
    Orv Hetil; 2010 May; 151(21):843-52. PubMed ID: 20462844
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.
    Cohen AT; Tapson VF; Bergmann JF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Zayaruzny M; Emery L; Anderson FA;
    Lancet; 2008 Feb; 371(9610):387-94. PubMed ID: 18242412
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk factors for thromboembolism in burn patients admitted to the burn unit at King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia.
    Althunayan TA; AlQarni SM; Mohsenh WA; Alkhalifah AM; Alsadi AN; Alrushid OS; Al-Qattan MM
    Saudi Med J; 2019 Oct; 40(10):1027-1031. PubMed ID: 31588482
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors.
    Hull RD; Merali T; Mills A; Stevenson AL; Liang J
    Clin Appl Thromb Hemost; 2013; 19(4):357-62. PubMed ID: 23610237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients.
    Dobesh PP; Stacy ZA
    J Manag Care Pharm; 2005; 11(9):755-62. PubMed ID: 16300419
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
    Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
    Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Concordance of Identified Cases of Pediatric HA-VTE with American College of Physicians and Cincinnati Children's Hospital HA-VTE Prophylaxis Guidelines Over a 10-Year Period.
    Fan EM; Lewis D; Presti T; El-Haj N; Chang WW
    Glob Pediatr Health; 2020; 7():2333794X20960279. PubMed ID: 33195742
    [No Abstract]   [Full Text] [Related]  

  • 71. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients.
    Le P; Martinez KA; Pappas MA; Rothberg MB
    J Thromb Haemost; 2017 Jun; 15(6):1132-1141. PubMed ID: 28371250
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Venous thrombosis in cancer patients: insights from the FRONTLINE survey.
    Kakkar AK; Levine M; Pinedo HM; Wolff R; Wong J
    Oncologist; 2003; 8(4):381-8. PubMed ID: 12897335
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study.
    Vallano A; Arnau JM; Miralda GP; Pérez-Bartolí J
    Thromb J; 2004 Apr; 2(1):3. PubMed ID: 15059286
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Venous thromboembolism prophylaxis in surgical patients: identifying a patient group to maximize performance improvement.
    Weigelt JA; Lal A; Riska R
    Jt Comm J Qual Patient Saf; 2011 Apr; 37(4):178-83. PubMed ID: 21500718
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Venous thromboembolism in medically ill patients: identifying risk and strategies for prevention.
    Wheeler A
    Clin Cornerstone; 2005; 7(4):23-31. PubMed ID: 16758649
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The AVAIL ME Extension: a multinational Middle Eastern survey of venous thromboembolism risk and prophylaxis.
    Mokhtari M; Salameh P; Kouchek M; Kashani BS; Taher A; Waked M;
    J Thromb Haemost; 2011 Jul; 9(7):1340-9. PubMed ID: 21605327
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of Venous Thromboembolism Prophylaxis in Neurological Patients with Restricted Mobility - VTE-NEURO Study.
    Bajenaru O; Antochi F; Balasa R; Buraga I; Patrichi S; Simu M; Szabolcs S; Tiu C; Zaharia C;
    Maedica (Bucur); 2014 Mar; 9(1):6-14. PubMed ID: 25553119
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Venous thromboembolism risk and antithrombotic prophylaxis among patients admitted to Spanish hospitals (ENDORSE study)].
    Nieto Rodríguez JA;
    Med Clin (Barc); 2009 Jun; 133(1):1-7. PubMed ID: 19446302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.